Dr. John LUK – Founder & CEO, Arbele Corp
Dr. John Luk is educated and trained at the University of Hong Kong, Karolinska (Stockholm), and Harvard (Boston). Prior to establishing Arbele, he was an academic professor for 18 years in the US, Hong Kong and Singapore, and a visiting associate professor at Harvard. Through his professorship at leading institutes, he was able to establish strong scientific, clinical, and industrial networks globally. He has published around 200 papers including NEJM, Cell, Nature Medicine, and Nature Genetics. Dr. John identified and patented CDH17 at HKU (Global Licensed to Arbele). In 2011, he found his path to the drug industry at Roche and Janssen Pharmaceutical, to lead drug discovery and development programs in oncology, immunology, and hepatitis.